Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results
- 1 October 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (3) , 597-601
- https://doi.org/10.1016/s0360-3016(99)00210-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinomaCancer, 1998
- Controversies in the management of locoregionally advanced nasopharyngeal carcinomaCurrent Opinion in Oncology, 1998
- Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.Journal of Clinical Oncology, 1998
- Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survivalInternational Journal of Radiation Oncology*Biology*Physics, 1996
- A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1995
- A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecologic oncology group studyGynecologic Oncology, 1989